BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Dainippon Sumitomo Pharma Co., Ltd. 

2-6-8 Doshomachi, Chuo-ku

Osaka    541-0045  Japan
Phone: 06-6203-5321 Fax: n/a


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Dainippon Sumitomo Pharma Co., Ltd. Halts Key Phase 3 Global Colorectal Carcinoma Monotherapy Trial 5/27/2014 7:31:54 AM
Edison Pharmaceuticals, Inc. Announces Initiation Of EPI-743 Phase 2B/3 Leigh Syndrome Clinical Trial With Dainippon Sumitomo Pharma Co., Ltd. In Japan 3/10/2014 12:29:22 PM
Edison Pharmaceuticals, Inc., Dainippon Sumitomo Pharma Co., Ltd. Ink "Biological Energy" Pact Worth $4.3 Billion 1/31/2014 6:48:05 AM
Retina Institute Japan and Dainippon Sumitomo Pharma Co., Ltd. Form a Capital Alliance Towards the Development of Nobel Prize Winning iPS Cell Technology 3/29/2013 9:07:02 AM
Edison Pharmaceuticals, Inc. Signs Licensing Agreement With Dainippon Sumitomo Pharma Co., Ltd. for Up to $545 Million 3/28/2013 7:35:41 AM
Dainippon Sumitomo Pharma Co., Ltd. Sumitomo Seeks SFDA Approval for Cancer Drug 9/4/2012 10:25:58 AM
Dainippon Sumitomo Pharma Co., Ltd. Reports that Latuda® (lurasidone HCl) Met Primary and Key Secondary Endpoints in Two Phase III Trials in Bipolar I Depression 5/7/2012 7:34:12 AM
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C’s Life Sciences Practice Represents Boston Biomedical in its Agreement with Dainippon Sumitomo Pharma Co., Ltd. to be Acquired for up to $2.63 Billion 3/5/2012 6:04:27 AM
Dainippon Sumitomo Pharma Co., Ltd. Bags Boston Biomedical for $2.6 Billion 2/29/2012 7:28:33 AM
Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells 4/7/2011 8:06:38 AM
1234